Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program

View ORCID ProfileNicholas R. Powell, View ORCID ProfileRenee C. Geck, Dongbing Lai, Tyler Shugg, Todd C. Skaar, View ORCID ProfileMaitreya Dunham
doi: https://doi.org/10.1101/2024.04.12.24305393
Nicholas R. Powell
1Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicholas R. Powell
  • For correspondence: nickpowe{at}iu.edu
Renee C. Geck
2University of Washington, Department of Genome Sciences, Seattle WA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Renee C. Geck
Dongbing Lai
3Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tyler Shugg
1Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd C. Skaar
1Indiana University School of Medicine, Department of Medicine, Division of Clinical Pharmacology, Indianapolis IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maitreya Dunham
2University of Washington, Department of Genome Sciences, Seattle WA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maitreya Dunham
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Glucose-6-phosphate dehydrogenase (G6PD) protects red blood cells against oxidative damage through regeneration of NADPH. Individuals with G6PD polymorphisms (variants) that produce an impaired G6PD enzyme are usually asymptomatic, but at risk of hemolytic anemia from oxidative stressors, including certain drugs and foods. Prevention of G6PD deficiency-related hemolytic anemia is achievable through G6PD genetic testing or whole-genome sequencing (WGS) to identify affected individuals who should avoid hemolytic triggers. However, accurately predicting the clinical consequence of G6PD variants is limited by over 800 G6PD variants which remain of uncertain significance. There also remains significant variability in which deficiency-causing variants are included in pharmacogenomic testing arrays across institutions: many panels only include c.202G>A, even though dozens of other variants can also cause G6PD deficiency. Here, we seek to improve G6PD genotype interpretation using data available in the All of Us Research Program and using a yeast functional assay. We confirm that G6PD coding variants are the main contributor to decreased G6PD activity, and that 13% of individuals in the All of Us data with deficiency-causing variants would be missed if only the c.202G>A variant were tested for. We expand clinical interpretation for G6PD variants of uncertain significance; reporting that c.595A>G, known as G6PD Dagua or G6PD Açores, and the newly identified variant c.430C>G, reduce activity sufficiently to lead to G6PD deficiency. We also provide evidence that five missense variants of uncertain significance are unlikely to lead to G6PD deficiency, since they were seen in hemi- or homozygous individuals without a reduction in G6PD activity. We also applied the new WHO guidelines and were able to classify two synonymous variants as WHO class C. We anticipate these results will improve the accuracy, and prompt increased use, of G6PD genetic tests through a more complete clinical interpretation of G6PD variants. As the All of Us data increases from 245,000 to 1 million participants, and additional functional assays are carried out, we expect this research to serve as a template to enable complete characterization of G6PD deficiency genotypes. With an increased number of interpreted variants, genetic testing of G6PD will be more informative for preemptively identifying individuals at risk for drug- or food-induced hemolytic anemia.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

R35 GM131812 (TCS), P30 CA015704 & R01 GM132162 (MD), F32 GM143852 & the Momental Foundation (RCG), K23 GM147805 (TS), PGRN Collaboration Grant (MD & NRP)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The All of Us data was openly accessible at the initiation of this study (https://allofus.nih.gov/)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All code used to generate the All of Us analyses is documented in the All of Us cloud computing platform as step-by-step notebooks in a dedicated workspace. We will share the workspace as read-only with approved users of the All of Us controlled tier data upon request. Code for analysis of S. cerevisiae functional assays are available at https://github.com/reneegeck/DunhamLab and strains are available upon request. All data produced in the present work are contained in the manuscript.

https://github.com/reneegeck/G6PDcat

https://github.com/reneegeck/DunhamLab

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 14, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program
Nicholas R. Powell, Renee C. Geck, Dongbing Lai, Tyler Shugg, Todd C. Skaar, Maitreya Dunham
medRxiv 2024.04.12.24305393; doi: https://doi.org/10.1101/2024.04.12.24305393
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program
Nicholas R. Powell, Renee C. Geck, Dongbing Lai, Tyler Shugg, Todd C. Skaar, Maitreya Dunham
medRxiv 2024.04.12.24305393; doi: https://doi.org/10.1101/2024.04.12.24305393

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)